Considering that FTO is an RNA demethylase frequently upregulated in many tumors and represents a risk factor for overall survival, K. pinnata emerges as a potential therapeutic option for aggressive cancers, such as hormone receptor-negative tumors. The gene discussed is FTO; the disease is cancer.